Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Karen Pharmaceutical Company is an Iranian healthcare company focused primarily on the commercial manufacture and distribution of nutritional supplements, sports nutrition products, dietary products, and enteral nutrition formulas. Publicly available descriptions indicate the company offers a broad portfolio across powders, tablets, capsules, soft gels, gummies, and hospital nutrition products, with more than 160-200 formulations cited across third-party sources. Karen appears to operate as a commercial-stage supplements and specialty nutrition business rather than a clinical-stage drug developer. The company is also linked to Karen National Distribution Company, which distributes Karen products and other pharmaceutical and supplement brands in Iran. Overall, Karen is best characterized as an active healthcare-related commercial nutrition and supplement manufacturer with a strong domestic presence in Iran.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Karen.